Clinical Trials Sponsored by Alexion
Total 403 results
-
Alexion PharmaceuticalsCompletedHypophosphatasiaUnited States, Germany
-
Alexion PharmaceuticalsCompletedHypophosphatasia (HPP)United States, Taiwan, United Kingdom, Australia, Canada, Germany, Spain
-
Alexion PharmaceuticalsCompletedHypophosphatasia (HPP)United States, Canada
-
Alexion PharmaceuticalsCompletedHypophosphatasia (HPP)United States, Canada
-
Alexion PharmaceuticalsCompletedHemoglobinuria, ParoxysmalUnited States
-
Alexion PharmaceuticalsCompletedMucopolysaccharidosis IIIBUnited States, United Kingdom, Spain
-
Alexion PharmaceuticalsCompletedParoxysmal Hemoglobinuria, NocturnalUnited States, Australia, Belgium, Canada, Germany, Italy, Spain, Sweden, United Kingdom, France, Ireland, Netherlands
-
Alexion PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria | PNHAustralia, France, United Kingdom, Belgium, Germany, Netherlands, Ireland, United States, Switzerland, Italy
-
Alexion PharmaceuticalsCompletedAtypical Hemolytic Uremic Syndrome (aHUS)Japan
-
Alexion PharmaceuticalsCompletedMPS IIIB (Sanfilippo Syndrome)Spain, Netherlands, United Kingdom, United States, Brazil
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | Cholesterol Ester Storage Disease(CESD)United States, United Kingdom, France, Canada, Czech Republic, Italy, Poland, Switzerland
-
Alexion PharmaceuticalsCompletedAtypical Hemolytic Uremic SyndromeFrance, United States, Austria, Germany, United Kingdom
-
Alexion PharmaceuticalsCompletedATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)Japan
-
Alexion PharmaceuticalsCompletedHemoglobinuria, ParoxysmalUnited States, Australia, Belgium, Canada, Germany, Italy, United Kingdom, France, Ireland, Netherlands, Sweden, Switzerland
-
Alexion PharmaceuticalsCompleted
-
Alexion PharmaceuticalsCompleted
-
Alexion PharmaceuticalsCompleted
-
Alexion PharmaceuticalsTerminatedPneumonia, Viral | Acute Respiratory Distress Syndrome | Acute Lung Injury | COVID-19 Severe PneumoniaUnited States, Spain, United Kingdom, France, Japan
-
Alexion PharmaceuticalsCompletedHealthyUnited Kingdom
-
Alexion PharmaceuticalsTerminatedAtypical Hemolytic Uremic SyndromeUnited States, Australia, Germany, United Kingdom
-
Alexion PharmaceuticalsTerminatedMyasthenia GravisUnited States, Canada, United Kingdom
-
Alexion PharmaceuticalsTerminatedNeuromyelitis Optica | Neuromyelitis Optica Spectrum DisorderHong Kong, United States, United Kingdom, Croatia, Malaysia, Korea, Republic of, Turkey, Japan, Italy, Spain, Taiwan, Australia, Argentina, Thailand, Russian Federation, Czechia, Denmark, Germany
-
Alexion PharmaceuticalsCompletedStage V Chronic Kidney DiseaseAustralia, France, Italy, Spain, United Kingdom, Sweden
-
Alexion PharmaceuticalsCompletedHypophosphatasia (HPP)United States, Canada
-
Alexion PharmaceuticalsApproved for marketingHypophosphatasiaUnited States, France
-
Alexion PharmaceuticalsCompletedHypophosphatasia | Bone DiseaseUnited States
-
Alexion PharmaceuticalsCompletedHypophosphatasiaUnited States, Spain, Australia, United Kingdom, Italy, France, Canada, Germany, Japan, Russian Federation, Saudi Arabia, Turkey
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | Cholesterol Ester Storage Disease(CESD) | LAL-DeficiencyFrance, United States, United Kingdom, Czechia
-
Alexion PharmaceuticalsTerminatedAntiphospholipid (aPL)-PositiveUnited States, Italy, Brazil, France, Japan, United Kingdom
-
Alexion PharmaceuticalsTerminatedLysosomal Acid Lipase DeficiencyUnited States
-
Alexion PharmaceuticalsTerminatedParoxysmal Nocturnal Hemoglobinuria (PNH)United States, Czech Republic, Italy, Poland, United Kingdom
-
Alexion PharmaceuticalsCompletedShiga-like Toxin-producing Escherichia ColiGermany
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompleted
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedHuman Immunodeficiency Virus (HIV)-1 InfectionUnited States, Spain, Germany, Dominican Republic
-
AlexionAchillion, a wholly owned subsidiary of AlexionCompletedHepatitis B, ChronicBulgaria, Former Yugoslavia
-
Alexion PharmaceuticalsTerminatedAmyotrophic Lateral Sclerosis | ALSUnited States, Spain, Italy, Belgium, Canada, Switzerland, Australia, Germany, Denmark, Israel, Sweden, France, Ireland, United Kingdom, Japan, Netherlands, Poland
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
Alexion PharmaceuticalsCompletedNeuromyelitis Optica | Neuromyelitis Optica Spectrum DisorderHong Kong, Korea, Republic of, United States, Croatia, Australia, Canada, Malaysia, Japan, Italy, Turkey, Spain, Taiwan, Argentina, Colombia, Czechia, Denmark, Germany, Russian Federation, Thailand, United Kingdom
-
Alexion PharmaceuticalsCompletedPNHKorea, Republic of, Australia
-
Alexion PharmaceuticalsWithdrawnThrombotic Microangiopathies | Stem Cell Transplant ComplicationsUnited States
-
Alexion PharmaceuticalsWithdrawnGeneralized Myasthenia GravisUnited States
-
Alexion PharmaceuticalsNo longer availableCOVID-19 | Pneumonia, Viral | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)United States, France
-
Alexion PharmaceuticalsCompleted
-
Alexion PharmaceuticalsWithdrawnWarm Autoimmune Hemolytic AnemiaUnited States
-
Alexion PharmaceuticalsTerminatedWarm Autoimmune Hemolytic AnemiaUnited States, Jordan
-
Alexion PharmaceuticalsTerminatedPemphigus | Pemphigus Vulgaris | Pemphigus FoliaceusUnited States
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase DeficiencySpain, Germany, Italy, United States, Croatia, Canada, Russian Federation, Denmark, United Kingdom, Belgium, Mexico, Australia, Netherlands, Brazil, Turkey
-
Alexion PharmaceuticalsTerminatedLysosomal Acid Lipase DeficiencyUnited Kingdom, Finland, United States, Italy